ABSTRACT. We investigated whether the tumor necrosis factor-a (TNF-α) promoter -238 A/G and -308 A/G polymorphisms are associated with rheumatoid arthritis (RA) and vitiligo susceptibility. MEDLINE and EMBASE databases and a manual search were used to identify articles in which TNF-α polymorphisms were determined in RA or vitiligo patients and controls. Meta-analysis was used to examine the associations between the TNF-α -238 A/G polymorphism and RA and vitiligo using the allelic contrast and dominant models. Fifteen studies (10 RA and 5 vitiligo) involving 3678 cases and 4400 controls were considered. We observed an association between the TNF-α -238 A allele and RA when all subjects were considered [odds ratio (OR) = 0.686, 95% confidence interval (CI) = 0.476-0.968, P = 0.043]. After stratification by ethnicity, we found no association between the TNF-α -238 A allele and RA in European or Asian populations. We observed no association between the TNF-α -308 A allele and vitiligo (OR = 1.787, 95%CI = 0.894-3.573, P = 0.101). However, the adjusted OR by the 5549 TNF-a polymorphisms, and RA, vitiligo ©FUNPEC-RP www.funpecrp.com.br Genetics and Molecular Research 14 (2): 5548-5559 (2015) trim-and-fill technique was significant (OR = 2.064, 95%CI = 1.138-3.743). After stratification by geographic continent, the TNF-α -308 A allele was significantly associated with vitiligo in Middle Eastern populations (OR = 1.569, 95%CI = 1.224-2.013, P = 3.8 x 10 -5 ). The TNF-α -238 A/G polymorphism was associated with RA susceptibility, and the TNF-a -308 A/G polymorphism may be a significant risk factor for vitiligo in Middle Eastern populations.
INTRODUCTION
Rheumatoid arthritis (RA) is a chronic inflammatory disease that mainly occurs in synovial joints and affects up to 1% of adults worldwide (Harris, 1990) . Vitiligo is a progressive depigmentation disorder characterized by the loss of functional melanocytes from the epidermis and affects 1-2% of the world's population (Mollet et al., 2007) . Although the etiology of RA and vitiligo remains unknown, a genetic component has been associated with the susceptibility to RA and vitiligo (Choi et al., 2006) .
Tumor necrosis factor-a (TNF-a) is a potent pro-inflammatory cytokine that plays important roles in inflammatory and immune responses, including those observed in RA and vitiligo (Rooney et al., 1995) . TNF stimulates cytokine production to enhance the expression of adhesion molecules and increase neutrophil activation. The TNF gene is located on chromosome 6, within the human leukocyte antigen class III region, and several single-nucleotide polymorphisms have been identified in its promoter (Allen, 1999) . Of these, the G-to-A substitution at positions -308 and -238 have been intensively studied, and some researchers have suggested that these allelic variations have functional significance (D'Alfonso and Richiardi, 1994) .
Several studies have examined the potential contributions of the TNF-α -238 A/G (rs361525) and -308 A/G (rs1800629) polymorphisms to the susceptibility to RA and vitiligo (Brinkman et al., 1997; Vinasco et al., 1997; van Krugten et al., 1999; Yen et al., 2001; Fabris et al., 2002; Zwiers et al., 2004; Correa et al., 2005; Rodríguez-Carreón et al., 2005; Yazici et al., 2006; Namian et al., 2009; Emonts et al., 2011; Laddha et al., 2012; Salinas-Santander et al., 2012; Al-Harthi et al., 2013; You et al., 2013) . However, the findings of these studies have been inconsistent, likely because of small sample sizes and low statistical power. Furthermore, allelic frequencies in genes often differ substantially between ethnicities or geographical regions; therefore, ethnicity/continent-specific association studies are needed to determine genetic associations in different populations (Lee et al., 2007 (Lee et al., , 2010 (Lee et al., , 2011 . In the present study, we conducted a meta-analysis to determine whether the TNF-α -238 A/G and -308 A/G polymorphisms were associated with susceptibility to RA and vitiligo in different populations.
MATERIAL AND METHODS

Identification of eligible studies and data extraction
A literature search was conducted to identify studies that examined associations between TNF-α polymorphisms and RA or vitiligo. The MEDLINE and EMBASE citation in-©FUNPEC-RP www.funpecrp.com.br Genetics and Molecular Research 14 (2): 5548-5559 (2015) dexes were used to identify articles published through April 2014, in which the presence of TNF-α polymorphism was determined in RA or vitiligo patients and controls. Combinations of key words such as "TNF-a", "TNF-a -238", "TNF-a -308", "polymorphism", "rheumatoid arthritis", "RA", and "vitiligo" were entered as both Medical Subject Headings and text words. In addition, all references were reviewed to identify additional studies not indexed by MEDLINE and EMBASE. Studies were included in the analysis if they were: 1) case-control studies; 2) included patients with RA or vitiligo; and 3) included genotype data for the TNF-α -238 A/G or -308 A/G polymorphism. No language restrictions were applied. Moreover, the following studies were excluded: 1) studies containing overlapping data; 2) studies in which the genotypes could not be ascertained; and 3) studies in which family members had been included and the analysis was based on linkage considerations. Information on the methods and results of the analyses were extracted from the original studies by 2 independent researchers. Disagreements were resolved by consensus or a third researcher. The following information was extracted from each study: 1) author, 2) year of publication, 3) ethnicity and geographical location of the study population, 4) numbers of cases and controls, and 5) the genotype and allele frequencies of the TNF-α polymorphism.
Evaluation of statistical associations
We examined the contrast between the allelic effect of the A allele and the G allele, and examined the contrast between the AA/AG and GG genotypes to analyze the dominant effect of the A allele. The point estimates of odds ratios (ORs) and their 95% confidence intervals (CIs) were determined for each study. Cochran's Q-statistics were used to assess within-and between-study variations and heterogeneities (Higgins and Thompson, 2002) . The heterogeneity test was used to assess the null hypothesis to ensure that all studies were evaluating the same effect. When a significant Q-statistic (P < 0.10) indicated heterogeneity across studies, the random-effects model was used for the meta-analysis; when heterogeneity across studies was not indicated, the fixed-effects model was used. Fixed-effects meta-analysis assumes that genetic factors have similar effects on disease susceptibility across all studies, and that observed variations between studies result from chance alone (Egger et al., 1997b) . The random-effects model assumes that different studies show substantial diversity and assesses both within-study sampling errors and between-study variance (DerSimonian and Laird, 1986) . We also quantified the effect of heterogeneity by using Higgins and Thompson, 2002) . I 2 ranges between 0 and 100% and represents the proportion of inter-study variability that can be attributed to heterogeneity rather than to chance. I 2 values of 25, 50, and 75% were defined as low, moderate, and high, respectively. Statistical manipulations were performed using the Comprehensive Meta-Analysis software (Biostat, Englewood, NJ, USA). The powers of the studies were computed as the probabilities of detecting associations between TNF-α polymorphisms and RA at a level of significance of 0.05, assuming a small effect size. Power analysis was performed using the statistical software G*Power (http:// www.psycho.uni-duesseldorf.de/aap/projects/gpower).
Evaluation of heterogeneity and publication bias
The chi-square test was used to determine whether the genotype frequency observed in controls was in Hardy-Weinberg equilibrium (HWE). We performed sensitiv-ity analysis by excluding studies in which the genotype distribution in controls was not consistent with HWE, as deviation from HWE among controls suggests biased control selection or genotyping errors. To examine the potential source of heterogeneity observed in the meta-analysis, meta-regression was performed using the following variables: ethnicity, publication year, and sample size. A funnel plot of effect size against standard error was used to detect publication bias. A funnel plot should be asymmetrical in the case of no publication bias. However, this method requires a range of studies of different sizes and involves subjective judgment; therefore, we evaluated publication bias using Egger's linear regression test (Egger et al., 1997a) , which measures funnel plot asymmetry using a natural logarithmic scale for ORs. When asymmetry was indicated, we used the trim-andfill method to adjust the summary estimate for the observed bias.
RESULTS
Studies included in the meta-analysis
Seventy-six relevant studies were identified, and 18 were selected for full-text review based on their titles and abstracts. Three were excluded because no extractable genotype data or family data were included. Thus, 15 studies met our inclusion criteria (Brinkman et al., 1997; Vinasco et al., 1997; van Krugten et al., 1999; Yen et al., 2001; Fabris et al., 2002; Zwiers et al., 2004; Correa et al., 2005; Rodríguez-Carreón et al., 2005; Yazici et al., 2006; Namian et al., 2009; Emonts et al., 2011; Laddha et al., 2012; Salinas-Santander et al., 2012; Al-Harthi et al., 2013; You et al., 2013) . Ten studies examined RA and 5 examined vitiligo. In total, the studies included 3678 cases and 4400 controls (2151 cases and 2156 controls for RA, 1527 cases and 2244 controls for vitiligo) ( Table 1) . They consisted of 6 European, 2 Asian, and 2 Latin American studies in RA. Ethnicity-specific meta-analysis was conducted on these populations in RA. Vitiligo studies included 3 Middle Eastern, 1 Asian, and 1 South American study based on continent. Selected characteristics regarding the relationships found between TNF-α polymorphisms and RA or vitiligo are summarized in Table 1 . The statistical powers of these studies ranged from 24.6 to 99.2%, and 3 studies had powers greater than 80% (Emonts et al., 2011; Laddha et al., 2012; You et al., 2013) .
Meta-analysis of the association between the TNF-α -238 A/G polymorphism and RA
The meta-analysis revealed an association between the TNF-α -238 A allele and RA when all subjects were considered (OR = 0.686, 95%CI = 0.476-0.968, P = 0.043) (Table 2, Figure 1 ). After stratification by ethnicity, the A allele was not associated with RA in European or Asian populations (Table 2) . Meta-analysis of the AA+AG genotype showed the same pattern of results as for the TNF-α -238 A allele. The meta-analysis indicated an association between the AA+AG genotype and RA when all subjects were considered (OR = 0.644, 95%CI = 0.432-0.962, P = 0.031), but stratification by ethnicity revealed no association between the AA/AG genotype an RA in each ethnic group (Table 2) . OR = odds ratio; CI = confidence interval; F = fixed-effects model; R = random-effects model, RA = rheumatoid arthritis. 
Meta-analysis of the association between the TNF-α -308 A/G polymorphism and vitiligo
The meta-analysis showed no association between the TNF-α -308 A allele and vitiligo when all subjects were considered (OR = 1.787, 95%CI = 0.894-3.573, P = 0.101) (Table 3, Figure 2 ). After stratification by continent, the A allele was significantly associated with vitiligo in the Middle Eastern group (OR = 1.569, 95%CI = 1.224-2.013, P = 3.8 x 10 -5 ) (Table 3, Figure 2 ). However, meta-analysis of the AA+AG genotype showed no association between the AA+AG genotype and vitiligo (Table 3) . *Adjusted by trim-and-fill method, OR = odds ratio; CI = confidence interval; F = fixed-effects model; R = randomeffects model, NA = Not available. 
Evaluation of heterogeneity and publication bias
The distributions of genotypes in normal control groups were not consistent with HWE in 1 study on RA (Correa et al., 2005) . However, excluding this study, the data did not materially affect our meta-analysis results regarding the associations between the TNF-α -238 A/G polymorphism and RA. Between-study heterogeneity was observed in meta-analyses of TNF-α polymorphisms and RA or vitiligo (Table 2 ). To examine the potential source of heterogeneity, meta-regression was performed. The results showed that ethnicity (P = 0.021), but not publication year and sample size, significantly impacted the heterogeneity in the TNF-α -238 A/G polymorphism in RA (Figure 3) . Meta-regression analysis revealed that the continent (P < 0.001), sample size (P < 0.001), and publication year (P = 0.005) contributed to the source of heterogeneity in the TNF-α -308 A/G polymorphism in vitiligo (Figure 3 ). Egger's regression test showed evidence of publication bias in the meta-analysis of the TNF-α polymorphisms in RA and vitiligo (Egger's regression test P values = 0.086, 0.044) (Figure 4 ). The adjusted OR by the trim-and-fill technique was not changed in RA, but became significant in vitiligo (OR = 2.064, 95%CI = 1.138-3.743) ( Table 2 ). 
DISCUSSION
TNF-α is located within the human leukocyte antigen class III region in chromosome 6, which has been shown to be the strongest linkage locus for autoimmune diseases. Although RA and vitiligo can have many causes, genetic factors are thought to be involved.
TNF-α -238
A/G and -308 A/G polymorphisms may be responsible for RA and vitiligo. The TNF-a -238 A/G and -308 A/G polymorphisms have been reported to be associated with several autoimmune disorders (Lee et al., 2006) . However, studies examining the associations between these polymorphisms and RA or vitiligo have shown conflicting results (Brinkman et al., 1997; Vinasco et al., 1997; van Krugten et al., 1999; Yen et al., 2001; Fabris et al., 2002; Zwiers et al., 2004; Correa et al., 2005; Rodríguez-Carreón et al., 2005; Yazici et al., 2006; Namian et al., 2009; Emonts et al., 2011; Laddha et al., 2012; Salinas-Santander et al., 2012; Al-Harthi et al., 2013; You et al., 2013) . Persistent difficulties regarding robust and replicable results in genetic association studies are almost certainly attributable to the small size of the effects of genetic variants, and therefore, a large number of study subjects is required to ensure adequate statistical power, such as a meta-analysis. A previous meta-analysis by Song et al. (2014) indicated that the TNF-α -308 A/G polymorphism was a significant risk factor for RA in Latin Americans but not in the European, Middle Eastern, or Asian populations.
In the present study, we conducted a meta-analysis of previously published data to evaluate the genetic association between the TNF-α -238 A/G and -308 A/G polymorphisms and susceptibility to RA and vitiligo. We found that the TNF-α -238 polymorphism was associated with significant susceptibility to RA when all subjects were considered. However, meta-analysis after stratification by ethnicity revealed no association between the TNF-α -238 A/G polymorphism and RA in European, Latin American, and Asian populations. This result may be explained by the small sample size in each group. We could not conduct ethnicity-specific meta-analysis of the TNF-α -308 A/G polymorphism in vitiligo because of the availability of only a single study in some ethnic groups. Instead, we carried out a meta-analysis stratified by geographical continent. Continent-specific meta-analysis revealed that the TNF-α -308 A/G polymorphism is a significant risk factor for vitiligo in Middle Eastern populations. TNF-a acts as a paracrine inhibitor of melanocytes and influences the process of apoptosis in melanocytes, which is considered to be an important susceptibility factor in vitiligo. Thus, our data indicate that the TNF-α -308 A/G polymorphism increases the risk of developing vitiligo.
The present study had some limitations. First, publication bias and heterogeneity may have distorted the meta-analyses. Second, the number of subjects and studies included in the ethnicity-specific meta-analyses was small. This study may not have enough power to explore the association between the TNF-α -238 A/G polymorphism and RA in all ethnic groups. Third, we could not perform an ethnic-specific analysis of the TNF-α -308 A/G polymorphism in vitiligo because of the limited number of studies within each ethnic group. Further studies are required in different ethnic populations because the prevalence of the TNF-α -308 A/G polymorphism varies depending on ethnicity. Fourth, the associations between these polymorphisms and disease activities and clinical features should be examined to obtain data stratified by gender or autoantibody status, but such analyses were not possible in this study because of limited or unavailable resources.
In conclusion, this meta-analysis showed that the TNF-α -238 A/G polymorphism was associated with susceptibility to RA, and the TNF-α -308 A/G polymorphism may represent a significant risk factor for vitiligo in Middle Eastern populations. These findings warrant further investigation into the associations between the TNF-α polymorphisms and susceptibility to RA and vitiligo. Studies of a larger scale in populations with different ethnicities are necessary to explore the roles of the polymorphisms of the TNF-α gene in the pathogeneses of RA and vitiligo.
